Pancreatic Cancer Clinical Trials

Showing 601-620 of 1,185 trials

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

NCT03871790

An international, multicenter study to identify tumor molecular particularities and neoepitopes among participants with colorectal and pancreatic tumors undergoing surgery.

Colon NeoplasmColon AdenocarcinomaColon Cancer+9 more

CENTOGENE GmbH Rostock50 participantsStarted Apr 2019

Lahore, Pakistan

UNKNOWN

Pancreatic Cancer Recurrence in the Netherlands

NCT04605237

The aim of this nationwide, observational cohort study is to evaluate current surveillance strategies after primary resection of pancreatic ductal adenocarcinoma (PDAC) in the Netherlands, with regard to the detection, treatment and survival of PDAC recurrence.

Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more

UMC Utrecht1,750 participantsStarted Jan 2014

Utrecht, Netherlands

UNKNOWN

Porto-Venous Radiomics in Pancreatic Cancer

NCT05700110

Multi-centre Retrospective Observational Cohort study of patients who underwent pancreaticoduodenectomy from 01/01/2005 to 01/02/2022 with histologically confirmed pancreatic head malignancy

Pancreatic Cancer

Royal Marsden NHS Foundation Trust800 participantsStarted May 2022

London, United Kingdom

COMPLETEDPhase 1/2

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

NCT02713529

A multi-center Phase 1b/2 study testing the combination of AMG 820 and pembrolizumab in subjects with select advanced solid tumors.

Pancreatic CancerColorectal CancerNon-Small Cell Lung Cancer

AmMax Bio, Inc.117 participantsStarted Apr 2016

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +12 more locations

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

Pancreatic Cancer Recurrence in the Netherlands

Porto-Venous Radiomics in Pancreatic Cancer

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

Related Searches

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

The Microbiome of Pancreatic Cancer: "PANDEMIC" Study

Registry of Subjects at Risk of Pancreatic Cancer

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

Cross-sectional Follow-up on Digestive and Social Functions of SPN

Early Detection of Pancreatic Cancer

Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer